Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Precigen Inc (NASDAQ: PGEN) was $1.33 for the day, up 0.76% from the previous closing price of $1.32. In other words, the price has increased by $0.76 from its previous closing price. On the day, 1.65 million shares were traded.
Ratios:
Our analysis of PGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 3.53. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.29.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 93.47.
Stock Price History:
Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -7.75%, while the 200-Day Moving Average is calculated to be 9.11%.
Shares Statistics:
A total of 295.14M shares are outstanding, with a floating share count of 161.93M. Insiders hold about 45.14% of the company’s shares, while institutions hold 27.25% stake in the company.
Earnings Estimates
The dynamic stock of Precigen Inc (PGEN) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.07 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.37 and -$0.37 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is $0.05, with 2.0 analysts recommending between $0.11 and -$0.01.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $21M, while the lowest revenue estimate was $2.84M, resulting in an average revenue estimate of $13.7M. In the same quarter a year ago, actual revenue was $3.92MBased on 3 analysts’ estimates, the company’s revenue will be $118.1M in the next fiscal year. The high estimate is $172.4M and the low estimate is $57.7M.
